Trial intelligence / Profile preview

Action of amantadine on post-stroke aphasic patients' language and communication

2008-003945-10Phase 2Completed

Sponsor
Centre Hospitalier Universitaire de Nice
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of amantadine in aphasia, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Verbal fluency performance. Started Mar 2009; status: completed.

02

Drugs

amantadine
03

Conditions

aphasia

Beyond the preview

Go deeper on 2008-003945-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003945-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call